| Dr Stephen D Krueger, MD | |
|
1004 Carondelet Dr, Suite 315, Kansas City, MO 64114-4802 | |
| (816) 942-3339 | |
| (816) 942-0606 |
| Full Name | Dr Stephen D Krueger |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 1004 Carondelet Dr, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104865393 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | R4E91 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen D Krueger, MD 1004 Carondelet Dr, Suite 315, Kansas City, MO 64114-4802 Ph: (816) 942-3339 | Dr Stephen D Krueger, MD 1004 Carondelet Dr, Suite 315, Kansas City, MO 64114-4802 Ph: (816) 942-3339 |
News Archive
Defenders of the status quo in health care would happily let the drive for reform bog down amid a debate over President Obama's new war strategy. Democrats can't let this happen (12/3).
Common viruses have become the latest weapon against cancer. There is the case of the eight-year-old African boy diagnosed with Burkitt's lymphoma at a Ugandan health clinic. He was exposed to the measles virus and in the next few weeks his tumour regressed completely and he entered remission. But only relatively recently have scientists clinically examined the interaction between viruses and cancers in the growing area of oncolytic virotherapy.
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
Researchers at the University of California, San Diego School of Medicine say a "stress response" mechanism used by normal cells to cope with harsh or demanding conditions is exploited by cancer cells, which transmit the same stress signal to surrounding cells, triggering an inflammatory response in them that can aid tumor growth.
Genentech, Inc. and Biogen Idec have announced that two global Phase III studies in chronic lymphocytic leukemia (CLL), CLL8 and REACH, showed Rituxan (rituximab) plus chemotherapy significantly increased the time patients lived without their disease advancing, as defined by the primary endpoint of progression-free survival (PFS), when compared to chemotherapy alone.
› Verified 9 days ago
Susan Marie Mou, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2101 Charlotte St, Kansas City, MO 64108 Phone: 816-404-7820 Fax: 816-404-8159 | |
Dr. Kristopher Shawn Lybarger, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd Bldg 2, Ste 546, Kansas City, MO 64132 Phone: 816-926-0777 Fax: 816-926-0707 | |
Ronald Edward Brunnabend Ii, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd Ste 598, Kansas City, MO 64132 Phone: 816-444-6888 | |
Douglas R Perryman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4400 Broadway Ste 302, Kansas City, MO 64111 Phone: 816-931-9344 Fax: 816-931-4168 | |
Anupama Kotha, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-3584 Fax: 816-932-5873 | |
Zachary James Alholm, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-0880 | |
Gerald Lee Miller Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6400 Prospect, #598, Kansas City, MO 64132 Phone: 816-444-6888 Fax: 816-444-1375 |